At the 2026 American Society of Clinical Oncology Annual Meeting poster session, we asked four scientists to discuss their research.
Listen to the episode to hear:
Peter Stanfield, of the University of Wisconsin, explains his research on cancer screening rates in transgender and gender-diverse people.
Nico Gotera, of the University of Texas Health Science Center, explains research on GLP-1 medicines and rates of breast cancer in postmenopausal women.
Anna Tanasijevic, of the Dana-Farber Cancer Institute, explains research on how much cancer survivors exercise.
Xianghui Zou, of NYU Langone Health, explains research on the timing of immunotherapy infusions for people with early-stage triple-negative breast cancer.
Podden och tillhörande omslagsbild på den här sidan tillhör
Breastcancer.org. Innehållet i podden är skapat av Breastcancer.org och inte av,
eller tillsammans med, Poddtoppen.
